Free Trial

LifeMD (LFMD) Competitors

LifeMD logo
$12.15 -0.30 (-2.41%)
As of 12:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LFMD vs. LFST, WGS, VCYT, ARDT, ADUS, PGNY, NHC, PACS, GRAL, and AHCO

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), Progyny (PGNY), National HealthCare (NHC), PACS Group (PACS), Grail (GRAL), and AdaptHealth (AHCO). These companies are all part of the "healthcare" industry.

LifeMD vs.

LifeMD (NASDAQ:LFMD) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

LifeStance Health Group has a net margin of -7.90% compared to LifeMD's net margin of -12.06%. LifeMD's return on equity of 0.00% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD-12.06% N/A -36.34%
LifeStance Health Group -7.90%-6.66%-4.51%

In the previous week, LifeMD had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 9 mentions for LifeMD and 3 mentions for LifeStance Health Group. LifeMD's average media sentiment score of 0.92 beat LifeStance Health Group's score of 0.90 indicating that LifeMD is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeMD
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeMD has higher earnings, but lower revenue than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$234.01M2.42-$20.60M-$0.34-36.62
LifeStance Health Group$1.28B1.78-$186.26M-$0.10-58.80

LifeMD has a beta of 2.42, indicating that its share price is 142% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 18.4% of LifeMD shares are owned by insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LifeMD presently has a consensus price target of $11.00, suggesting a potential downside of 11.65%. LifeStance Health Group has a consensus price target of $8.50, suggesting a potential upside of 44.56%. Given LifeStance Health Group's higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than LifeMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.00
LifeStance Health Group
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

LifeMD received 24 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 76.92% of users gave LifeMD an outperform vote while only 34.04% of users gave LifeStance Health Group an outperform vote.

CompanyUnderperformOutperform
LifeMDOutperform Votes
40
76.92%
Underperform Votes
12
23.08%
LifeStance Health GroupOutperform Votes
16
34.04%
Underperform Votes
31
65.96%

Summary

LifeMD beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$565.83M$1.79B$5.51B$8.63B
Dividend YieldN/AN/A5.27%4.18%
P/E Ratio-19.4528.0027.1720.15
Price / Sales2.421.74410.84161.53
Price / CashN/A36.0138.2534.64
Price / Book83.0018.026.964.72
Net Income-$20.60M-$52.07M$3.23B$248.00M
7 Day Performance-1.58%-0.52%6.40%4.54%
1 Month Performance50.73%17.85%13.89%10.02%
1 Year Performance64.68%77.72%32.16%14.88%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
1.5901 of 5 stars
$12.15
-2.4%
$11.00
-9.5%
+65.1%$552.19M$234.01M-18.98230
LFST
LifeStance Health Group
2.1029 of 5 stars
$5.88
-1.0%
$8.50
+44.6%
+4.1%$2.29B$1.28B-22.626,640
WGS
GeneDx
3.2659 of 5 stars
$74.13
+4.1%
$86.75
+17.0%
+189.6%$2.12B$330.14M-37.821,200Positive News
VCYT
Veracyte
4.1998 of 5 stars
$26.74
+0.5%
$40.90
+53.0%
+34.9%$2.09B$463.39M-178.27790
ARDT
Ardent Health Partners
3.2773 of 5 stars
$14.43
-0.4%
$20.67
+43.3%
N/A$2.06B$6.02B8.8524,200Positive News
ADUS
Addus HomeCare
4.5724 of 5 stars
$111.20
+0.3%
$142.57
+28.2%
+1.8%$2.05B$1.21B25.4533,200Positive News
PGNY
Progyny
1.0437 of 5 stars
$21.70
+0.9%
$23.45
+8.1%
-20.4%$1.84B$1.21B37.41310Positive News
NHC
National HealthCare
N/A$103.58
-0.5%
N/A+1.3%$1.60B$1.37B12.9812,400Positive News
PACS
PACS Group
3.6201 of 5 stars
$9.83
-0.9%
$34.29
+248.8%
-64.7%$1.50B$3.56B0.0032,433
GRAL
Grail
0.3721 of 5 stars
$37.50
-2.4%
$31.50
-16.0%
N/A$1.35B$130.71M-0.611,360
AHCO
AdaptHealth
3.3105 of 5 stars
$8.75
-2.6%
$13.40
+53.1%
-21.3%$1.21B$3.25B-5.3010,900Positive News

Related Companies and Tools


This page (NASDAQ:LFMD) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners